Latest Market Entry News

Page 10 of 41
Island Pharmaceuticals has inked a Master Service Agreement with Texas Biomedical Research Institute, enhancing its strategic position to advance Galidesivir through the FDA Animal Rule pathway. This partnership aligns with US government priorities on viral threats and sets the stage for a planned clinical program in early 2026.
Victor Sage
Victor Sage
17 Dec 2025
Talga Group has opened a $5 million Share Purchase Plan at $0.41 per share, offering shareholders free attaching and piggyback options to support its planned anode production ramp-up and US expansion.
Maxwell Dee
Maxwell Dee
17 Dec 2025
ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.
Ada Torres
Ada Torres
16 Dec 2025
Greenvale Energy has successfully scaled its Alpha Torbanite Project test program by 40 times and commenced bulk sample production aiming for commercial bitumen certification.
Maxwell Dee
Maxwell Dee
16 Dec 2025
Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.
Ada Torres
Ada Torres
15 Dec 2025
Prairie Lithium has locked in a decade-long agreement to supply lithium-bearing crystallite to Hydro Lithium’s South Korean refinery, marking a strategic step in its commercial-scale production and market entry.
Maxwell Dee
Maxwell Dee
11 Dec 2025
Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.
Ada Torres
Ada Torres
10 Dec 2025
Merino & Co. has secured a significant new order from its Shanghai distribution partner, reinforcing its expanding footprint in China’s luxury apparel market and validating its strategic growth plans.
Victor Sage
Victor Sage
9 Dec 2025
Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.
Ada Torres
Ada Torres
8 Dec 2025
Ovanti Limited’s US subsidiary has secured a key partnership with Mastercard’s Finicity to enhance its upcoming Flote BNPL platform, aiming to revolutionize consumer finance with real-time data insights.
Victor Sage
Victor Sage
8 Dec 2025
Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.
Ada Torres
Ada Torres
4 Dec 2025
Lotus Resources reports promising progress at its Kayelekera uranium mine, targeting steady state production by Q1 2026 despite recent sulphuric acid supply constraints. The company is addressing supply issues with new sourcing and an on-schedule acid plant rebuild.
Maxwell Dee
Maxwell Dee
4 Dec 2025